Cannabis Investing | Khiron (KHRNF), Lexaria (LEXX), and more | with Ted Ohashi

We chat with Ted Ohashi, writer of “The Cannabis Report,” about hot topics in the cannabis industry. New developments with Khiron and Lexaria as well as the industry as a whole.

0:00 Intro with Disclaimer
0:42 Lexaria (LEXX)
2:59 Khiron (KHRNF)
4:39 10 Years From Now
6:51 Cannabis Restrictions Good?
8:29 Final Thoughts

Lexaria (LEXX): https://ih.advfn.com/stock-market/NASDAQ/lexaria-bioscience-LEXX/stock-price

Khiron (KHRNF): https://ih.advfn.com/stock-market/USOTC/khiron-life-sciences-qx-KHRNF/stock-price

Website: https://investorshub.advfn.com/

Market Vision Twitter: https://twitter.com/IHub_Vision

Investors Hub Twitter: https://twitter.com/Investors_Hub

Talk with me on the Market Vision forum: https://investorshub.advfn.com/Investors-Hub-Market-Vision-38574/

Investors Hub LinkedIn: https://www.linkedin.com/company/investorshub-com-inc-

Investors Hub Facebook: https://www.facebook.com/InvestorsHub

#stocks #investing #cannabis

Posted in Investors

1 Comment

  1. Happy Glass on May 25, 2022 at 11:29 pm

    They have had synthetic cannabis for years and they failed because the best results come from the entourage effect. I can see that for the rare cannabanoids like cbg. Thank you for your insights.
    I have a different investment strategy for the cannabis space. I am betting on the public companies that are thriving in the competitive environments where people are actually discerning when it comes to cannabis. If they can thrive in Cali and Oregon and stand out with their product they will take over the entire country when the playing field is leveled